COEP — Z Squared Inc.
—
Nasdaq ·
Financials ·
Consumer Finance ·
CIK 1759186 ·
Last close
$16.40
Market Cap
$102.06M
52W High
$17.27
52W Low
$9.78
ADV30
53,168
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 862,049 | 816,892 | -1,988,272 | -1,577,869 | 16,153,921 | 5,674,302 | 2,085,764 |
| Sep 2025 | 237,441 | 192,286 | -2,477,028 | -2,739,403 | 14,181,641 | 4,908,487 | 3,264,864 |
| Jun 2025 | 200,681 | 155,524 | -4,521,214 | -3,534,595 | 12,191,479 | 1,996,726 | 5,111,349 |
| Mar 2025 | 62,874 | 17,718 | -4,056,984 | -3,057,730 | 13,453,067 | 4,268,368 | 5,990,153 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,603,036
Investing CF
$0
Financing CF
$13,744,453
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.64
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-109,953,728
Inventory
—
Receivables
$7,348
ST Investments
$676,596
EBIT TTM
$-11,634,813
Pretax Income TTM
$-12,277,192
Interest Exp TTM
$642,379
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,363,045
EBITDA
$-11,862,286
Free Cash Flow
$-3,030,945
Enterprise Value
$96,484,968
Total Cash
$6,350,898
Total Debt
$268,875
Shares Out
6,223,221
Trailing EPS
$-2.81
Book Value
$2.36
ROE
-136.9%
ROA
-65.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,363,045 | -13,043,498 | -11,917,015 | 16,153,921 | 2,085,764 | — | -8,603,036 |
| Dec 2024 | 0 | -10,054,488 | -10,680,452 | 8,908,660 | 5,041,434 | — | -6,649,281 |
| Dec 2023 | 0 | -21,491,125 | -21,266,537 | 4,571,089 | 3,757,125 | — | -7,239,514 |
| Dec 2022 | 0 | -34,195,964 | -37,574,217 | 7,915,689 | 3,462,360 | — | -3,875,811 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.17
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XYF | X Financial | $98.34M | $4.42 | — |
| JFIN | Jiayin Group Inc. | $106.13M | $4.19 | — |
| NAKA | Nakamoto Inc. | $95.54M | $5.49 | — |
| MGTE | Marblegate Capital Corp | $94.61M | $1.28 | — |
| UPXI | UPEXI, INC. | $91.34M | $1.30 | — |
News headlines (Yahoo Finance, 1h cache)
Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution
2026-04-27 15:30 · Yahoo
Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market
2026-04-24 20:43 · Yahoo
Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build
2026-03-09 12:07 · Yahoo
Vanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform
2026-02-04 09:15 · Yahoo
CSG Systems International Extraordinary General Meeting: Shareholders Back Key Proposals, Merger Actions
2026-01-30 16:28 · Yahoo
Coeptis Therapeutic Holdings Details $835M Transaction Structure with Z-Squared; Vanderbilt Report Publishes Coverage
2026-01-06 13:31 · Yahoo
Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
2025-10-01 12:07 · Yahoo
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
2025-07-22 12:36 · Yahoo
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
2025-05-28 12:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.